Abstract
Event Abstract Back to Event Design of viral-mimetic surfaces to recognize tumor glycolipids using hemagglutinating virus of japan envelope (HVJ-E) Takaharu Okada1, Koichiro Uto1, Takao Aoyagi1, Chun Man Lee2 and Mitsuhiro Ebara1 1 National Institute for Materials Science (NIMS), Biomaterials Unit, Japan 2 Osaka University Hospital, Medical Center for Translational Research, Japan Our study reports a versatile immobilization method of Hemagglutinating Virus of Japan Envelope (HVJ-E) for the generation of viral-mimetic surfaces for metastatic prostate cancer cells isolation. HVJ-E has recently attracted much attention as a new type of therapeutic materials because metastatic prostate cancer cells such as PC-3 cells possess the HVJ-E receptors, GD1a. The HVJ-E was successfully immobilized on precursor films composed of poly-L-lysine and alginic acid via layer-by-layer assembly without changing the biological activity. The monolayer adsorption of HVJ-E particles was confirmed by quartz crystal microbalance, fluorescent and atomic force microscopy analyses. By developing the HVJ-E coating with an affinity based cell trap within a glass capillary tube, we are able to gently isolate PC-3 from LN-Cap cells that represent adenocarcinoma without compromising cell viability. We achieved approximately 100 % cell separation efficiency only by 60 seconds of flowing. We believe that the proposed technique offers significant promise for the creation of a metastatic cancer cells trap on a broad range of materials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.